<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00562393</url>
  </required_header>
  <id_info>
    <org_study_id>EXCESS</org_study_id>
    <secondary_id>427639</secondary_id>
    <nct_id>NCT00562393</nct_id>
  </id_info>
  <brief_title>Effects of Excess Energy Intake on Metabolic Risk</brief_title>
  <acronym>EXCESS</acronym>
  <official_title>Effects of Excess Energy Intake on Metabolic Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Garvan Institute of Medical Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Garvan Institute of Medical Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of obesity has reached epidemic proportions and is associated with the
      development of insulin resistance and type 2 diabetes (T2DM). A unifying theme has emerged
      over the past few years suggesting that lipid oversupply to metabolic organs responsible for
      glucose regulation leads to insulin resistance. Fitting with this, we and others have shown
      that increased lipid accumulation within skeletal muscle and/or liver is associated with
      impaired glucose uptake. However, the underlying mechanisms that mediate changes in muscle
      lipid metabolism are not yet known. The overall aim of this project is to examine metabolic
      effects of experimental weight gain in lean and overweight individuals with and without a
      genetic predisposition to type 2 diabetes. We hypothesise that lean subjects will increase
      fatty acid oxidation and upregulate mitochondrial oxidative capacity in muscle following
      overfeeding to protect against body weight gain and insulin resistance, but overweight
      subjects with a genetic predisposition to T2DM will have a defect in this ability.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitiviy by hyperinsulinemic clamp</measure>
    <time_frame>28-days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fat oxidation (whole body RQ and C-14 palmitate), mitochondrial function</measure>
    <time_frame>28-days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Overfeeding</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 weeks of 1250 kcal added daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional</intervention_name>
    <description>Overfeeding high fat diet for 28 days</description>
    <arm_group_label>Overfeeding</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sedentary (&lt;60 min formal exercise per week)

          -  Aged 20-65 years

        Exclusion Criteria:

          -  Personal history of diabetes, cardiovascular disease or hypertension

          -  Recent weight change (larger than 4kg in the past 3 months)

          -  Smoking

          -  Regular use of medications, except oral contraceptives

          -  Individuals with alcoholism or other substance abuse

          -  Pregnancy or lactation, women who are planning to become pregnant or who are not using
             adequate measures of birth control.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonie K Heilbronn, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Garvan Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lesley M Campbell, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Garvan Insititute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Garvan Institute of Medical Research</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <results_reference>
    <citation>Tam CS, Viardot A, Cl√©ment K, Tordjman J, Tonks K, Greenfield JR, Campbell LV, Samocha-Bonet D, Heilbronn LK. Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans. Diabetes. 2010 Sep;59(9):2164-70. doi: 10.2337/db10-0162. Epub 2010 Jun 14.</citation>
    <PMID>20547978</PMID>
  </results_reference>
  <results_reference>
    <citation>Samocha-Bonet D, Campbell LV, Viardot A, Freund J, Tam CS, Greenfield JR, Heilbronn LK. A family history of type 2 diabetes increases risk factors associated with overfeeding. Diabetologia. 2010 Aug;53(8):1700-8. doi: 10.1007/s00125-010-1768-y. Epub 2010 May 12.</citation>
    <PMID>20461357</PMID>
  </results_reference>
  <results_reference>
    <citation>Sato K, Samocha-Bonet D, Handelsman DJ, Fujita S, Wittert GA, Heilbronn LK. Serum sex steroids and steroidogenesis-related enzyme expression in skeletal muscle during experimental weight gain in men. Diabetes Metab. 2014 Dec;40(6):439-44. doi: 10.1016/j.diabet.2014.03.006. Epub 2014 Apr 30.</citation>
    <PMID>24792219</PMID>
  </results_reference>
  <results_reference>
    <citation>Samocha-Bonet D, Tam CS, Campbell LV, Heilbronn LK. Raised circulating fetuin-a after 28-day overfeeding in healthy humans. Diabetes Care. 2014;37(1):e15-6. doi: 10.2337/dc13-1728.</citation>
    <PMID>24356603</PMID>
  </results_reference>
  <results_reference>
    <citation>Heilbronn LK, Coster AC, Campbell LV, Greenfield JR, Lange K, Christopher MJ, Meikle PJ, Samocha-Bonet D. The effect of short-term overfeeding on serum lipids in healthy humans. Obesity (Silver Spring). 2013 Dec;21(12):E649-59. doi: 10.1002/oby.20508. Epub 2013 Jul 29.</citation>
    <PMID>23640727</PMID>
  </results_reference>
  <results_reference>
    <citation>Heilbronn LK, Campbell LV, Xu A, Samocha-Bonet D. Metabolically protective cytokines adiponectin and fibroblast growth factor-21 are increased by acute overfeeding in healthy humans. PLoS One. 2013 Oct 18;8(10):e78864. doi: 10.1371/journal.pone.0078864. eCollection 2013.</citation>
    <PMID>24205333</PMID>
  </results_reference>
  <results_reference>
    <citation>Samocha-Bonet D, Campbell LV, Mori TA, Croft KD, Greenfield JR, Turner N, Heilbronn LK. Overfeeding reduces insulin sensitivity and increases oxidative stress, without altering markers of mitochondrial content and function in humans. PLoS One. 2012;7(5):e36320. doi: 10.1371/journal.pone.0036320. Epub 2012 May 7.</citation>
    <PMID>22586466</PMID>
  </results_reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2007</study_first_submitted>
  <study_first_submitted_qc>November 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2007</study_first_posted>
  <last_update_submitted>July 13, 2015</last_update_submitted>
  <last_update_submitted_qc>July 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Garvan Institute of Medical Research</investigator_affiliation>
    <investigator_full_name>Dr Jerry Greenfield</investigator_full_name>
    <investigator_title>Head of Endocrinology Department St Vincent's Hospital Sydney</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

